Angiotensin converting enzyme activity is positively associated with IL-17a levels in patients with schizophrenia

Ary Gadelha,Camila M. Yonamine,Marcela Nering,Lucas Bortolotto Rizzo,Cristiano Noto,Hugo Cogo-Moreira,Antônio Lúcio Teixeira,Rodrigo Bressan,Michael Maes,Elisa Brietzke,Mirian A.F. Hayashi
DOI: https://doi.org/10.1016/j.psychres.2015.08.018
IF: 11.3
2015-01-01
Psychiatry Research
Abstract:Previous studies of our group showed increased plasmatic Angiotensin-I Converting Enzyme (ACE) activity in schizophrenia (SCZ) patients compared to healthy controls, which was also associated to poor cognitive functioning. The ACE main product angiotensin II (Ang-II) has pro-inflammatory properties. Activated immune-inflammatory responses in SCZ and their association with disease progression and cognitive impairments are also well-described. Therefore, we examined here the association of plasma ACE activity and inflammatory mediators in 33 SCZ patients and 92 healthy controls. Non-parametric correlations were used to investigate the association of the enzyme activity and the peripheral levels of immune inflammatory markers as interleukins, tumor necrosis factor (TNF-α), and interferon (IFN-γ). Although no significant correlations could be observed for ACE activity and measured cytokines levels in healthy controls, a significant positive correlation for ACE enzymatic activity and IL-17a levels was observed in SCZ patients. Correcting for gender did not change these results. Moreover, a significant association for ACE activity and IFN-γ levels was also observed. To our knowledge, this is the first study to show a significant association between higher ACE activity and the levels of cytokines, namely IL-17a and IFN-γ, in patients with SCZ.
What problem does this paper attempt to address?